Open Access<p>IL-6/STAT3 Signaling Contributes to Sorafenib Resistance in Hepatocellular Carcinoma Through Targeting Cancer Stem Cells [Corrigendum]</p>
Author(s) -
Yu Liu,
Gang Chen,
ZeGuang Han,
Hongwei Cheng,
Liang Qiao,
Yumin Li
Publication year - 2020
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s292577
Subject(s) - sorafenib , hepatocellular carcinoma , cancer research , medicine , stat3 , cancer stem cell , liver cancer , cancer , oncology , signal transduction , biology , microbiology and biotechnology
[This corrects the article DOI: 10.2147/OTT.S262089.].